Literature DB >> 10390526

6-Thioguanine alters the structure and stability of duplex DNA and inhibits quadruplex DNA formation.

V M Marathias1, M J Sawicki, P H Bolton.   

Abstract

The ability to chemically synthesize biomolecules has opened up the opportunity to observe changes in structure and activity that occur upon single atom substitution. In favorable cases this can provide information about the roles of individual atoms. The substitution of 6-thioguanine (6SG) for guanine is a potentially very useful single atom substitution as 6SG has optical, photocrosslinking, metal ion binding and other properties of potential utility. In addition, 6-mercaptopurine is a clinically important pro-drug that is activated by conversion into 6SG by cells. The results presented here indicate that the presence of 6SG blocks the formation of quadruplex DNA. The presence of 6SG alters the structure and lowers the thermal stability of duplex DNA, but duplex DNA can be formed in the presence of 6SG. These results indicate that some of the cytotoxic activity of 6SG may be due to disruption of the quadruplex structures formed by telomere and other DNAs. This additional mode of action is consistent with the delayed onset of cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10390526      PMCID: PMC148499          DOI: 10.1093/nar/27.14.2860

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Structural effect of the anticancer agent 6-thioguanine on duplex DNA.

Authors:  Jen Bohon; Carlos R de los Santos
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

3.  Resolution of quadruplex polymorphism by size-exclusion chromatography.

Authors:  M Clarke Miller; John O Trent
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2011-06

4.  Polymorphism and resolution of oncogene promoter quadruplex-forming sequences.

Authors:  M Clarke Miller; Huy T Le; William L Dean; Patrick A Holt; Jonathan B Chaires; John O Trent
Journal:  Org Biomol Chem       Date:  2011-09-21       Impact factor: 3.876

5.  Multivariate curve resolution: a powerful tool for the analysis of conformational transitions in nucleic acids.

Authors:  Joaquim Jaumot; Núria Escaja; Raimundo Gargallo; Carlos González; Enrique Pedroso; Romà Tauler
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

6.  Molecular dynamics of DNA quadruplex molecules containing inosine, 6-thioguanine and 6-thiopurine.

Authors:  R Stefl; N Spacková; I Berger; J Koca; J Sponer
Journal:  Biophys J       Date:  2001-01       Impact factor: 4.033

Review 7.  In What Ways Do Synthetic Nucleotides and Natural Base Lesions Alter the Structural Stability of G-Quadruplex Nucleic Acids?

Authors:  Janos Sagi
Journal:  J Nucleic Acids       Date:  2017-10-18

8.  Guanine analogues enhance antisense oligonucleotide-induced exon skipping in dystrophin gene in vitro and in vivo.

Authors:  Yihong Hu; Bo Wu; Allen Zillmer; Peijuan Lu; Ehsan Benrashid; Mingxing Wang; Timothy Doran; Mona Shaban; Xiaohua Wu; Qi Long Lu
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

9.  Calculation of hydrodynamic properties for G-quadruplex nucleic acid structures from in silico bead models.

Authors:  Huy T Le; Robert Buscaglia; William L Dean; Jonathan B Chaires; John O Trent
Journal:  Top Curr Chem       Date:  2013

10.  Conformationally rigid nucleoside probes help understand the role of sugar pucker and nucleobase orientation in the thrombin-binding aptamer.

Authors:  Hisao Saneyoshi; Stefania Mazzini; Anna Aviñó; Guillem Portella; Carlos González; Modesto Orozco; Víctor E Marquez; Ramon Eritja
Journal:  Nucleic Acids Res       Date:  2009-07-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.